INOVIO to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
INOVIO (NASDAQ:INO), a biotechnology company specializing in DNA medicines for HPV-associated diseases, cancer, and infectious diseases, will participate in the H.C. Wainwright 27th Annual Global Investment Conference.
The company will provide a pre-recorded presentation available on demand starting September 5, 2025, at 7:00 AM ET. INOVIO's management team will conduct in-person one-on-one meetings with investors during the conference. The webcast will remain accessible for 90 days through the provided link and INOVIO's Investor Relations Events page.
INOVIO (NASDAQ:INO), azienda biotecnologica specializzata in terapie a base di DNA per malattie associate a HPV, tumori e malattie infettive, parteciperà alla H.C. Wainwright 27th Annual Global Investment Conference.
L'azienda renderà disponibile una presentazione preregistrata on demand a partire dal 5 settembre 2025 alle 7:00 AM ET. Il team dirigenziale di INOVIO terrà incontri individuali in presenza con gli investitori durante la conferenza. Il webcast sarà accessibile per 90 giorni tramite il link fornito e la pagina Eventi Investor Relations di INOVIO.
INOVIO (NASDAQ:INO), compañía biotecnológica especializada en medicamentos de ADN para enfermedades asociadas al VPH, cáncer y enfermedades infecciosas, participará en la H.C. Wainwright 27th Annual Global Investment Conference.
La empresa ofrecerá una presentación grabada disponible on demand a partir del 5 de septiembre de 2025 a las 7:00 AM ET. El equipo directivo de INOVIO mantendrá reuniones individuales presenciales con inversores durante la conferencia. El webcast permanecerá accesible durante 90 días a través del enlace facilitado y de la página de Eventos de Relaciones con Inversores de INOVIO.
INOVIO (NASDAQ:INO))는 HPV 관련 질환, 암 및 전염병을 위한 DNA 의약품을 전문으로 하는 생명공학 기업으로, H.C. Wainwright 27th Annual Global Investment Conference에 참가합니다.
회사는 2025년 9월 5일 오전 7:00(미국 동부 시간)부터 주문형으로 시청 가능한 사전 녹화 발표 영상을 제공합니다. INOVIO 경영진은 컨퍼런스 기간 동안 투자자들과 대면 1:1 미팅을 진행할 예정입니다. 웹캐스트는 제공된 링크와 INOVIO 투자자 관계 이벤트 페이지를 통해 90일간 계속 이용할 수 있습니다.
INOVIO (NASDAQ:INO), société de biotechnologie spécialisée dans les médicaments à base d'ADN pour les maladies liées au HPV, le cancer et les maladies infectieuses, participera à la H.C. Wainwright 27th Annual Global Investment Conference.
La société proposera une présentation préenregistrée disponible à la demande à partir du 5 septembre 2025 à 7:00 AM ET. L'équipe de direction d'INOVIO tiendra des réunions individuelles en personne avec des investisseurs pendant la conférence. Le webcast restera accessible pendant 90 jours via le lien fourni et la page Événements des Relations Investisseurs d'INOVIO.
INOVIO (NASDAQ:INO), ein Biotechnologieunternehmen, das sich auf DNA-Medikamente für HPV-assoziierte Erkrankungen, Krebs und Infektionskrankheiten spezialisiert hat, wird an der H.C. Wainwright 27th Annual Global Investment Conference teilnehmen.
Das Unternehmen stellt ab dem 5. September 2025 um 7:00 AM ET eine vorab aufgezeichnete Präsentation On-Demand zur Verfügung. Das Management von INOVIO wird während der Konferenz persönliche Einzelgespräche mit Investoren führen. Der Webcast bleibt für 90 Tage über den bereitgestellten Link und die Investor-Relations-Eventseite von INOVIO zugänglich.
- None.
- None.
H.C. Wainwright 27th Annual Global Investment Conference
Presentation available: Beginning Friday, September 5, 2025, 7:00AM ET
Format: Pre-recorded webcast
Link: https://journey.ct.events/view/c0cc4d12-f619-4d58-878f-4ee305e4f2c2
The webcast will be available for 90 days at the link above or on the INOVIO Investor Relations Events page: https://ir.inovio.com/events-and-presentations/default.aspx.
About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.
Contacts
Media: Jennie Willson, (267) 429-8567, communications@inovio.com
Investors: Peter Vozzo, ICR Healthcare, 443-213-0505, investor.relations@inovio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-participate-in-the-hc-wainwright-27th-annual-global-investment-conference-302536840.html
SOURCE INOVIO Pharmaceuticals, Inc.
FAQ
When is INOVIO's presentation at the H.C. Wainwright Conference 2025?
How long will INOVIO's H.C. Wainwright Conference presentation be available?
What type of meetings will INOVIO conduct at the H.C. Wainwright Conference?
Where can investors access INOVIO's H.C. Wainwright Conference presentation?
